Connect with us

Latest

Ireland halts use of AstraZeneca vaccine following blood clot reports in Norway

Published

on

[ad_1]

The Norwegian drug agency said on Saturday that there were four new cases of severe blood clotting in adults after taking the vaccine.

The National Immunization Advisory Committee of Ireland (NIAC) adopted the directive as a precaution, although “it has not been concluded that there is any link between the AstraZeneca vaccine and these cases,” it said in a statement.

The Irish NIAC will meet again on Sunday to discuss more about the vaccine suspension, he added.

Ireland is the last of the chain of European countries who have decided to partially or completely suspend the deployment of the AstraZeneca vaccine following reports of patients developing blood clots after inoculations.

Austrian health authorities were the first to sound the alarm about the possible dangers of the vaccine, and suspended a batch of doses on Tuesday.

On Friday, Italy banned the use of vaccines from a specific batch of AstraZeneca doses after the death of a soldier in Sicily who had died of cardiac arrest a day after receiving the first dose of vaccine. .

Denmark, however, on Thursday became the first European country to temporarily suspend all implementation of the AstraZeneca vaccine.

The European Union’s drug regulator, the EMA, is currently investigating whether the shooting could be related to several reports of blood clots.

The EMA has said that the benefits of the AstraZeneca vaccine outweigh the risks and do not recommend stopping its use.

“There are currently no indications that the vaccination has caused these conditions, which are not listed as side effects with this vaccine,” the EMA said in a statement on Thursday.

To date, more than 110,000 doses of the AstraZeneca vaccine have been administered in Ireland, representing approximately 20% of all doses in the country according to the state broadcaster RTÉ.

CNN has contacted AstraZeneca to comment.

Niamh Kennedy reported from Dublin and Lindsay Isaac reported from London.

.

[ad_2]